UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer
UBR1 is overexpressed in STAD, promoting its progression and positively correlating with immune cell infiltration and immunotherapeutic responses. Therefore, UBR1 could be a promising biomarker for the prognosis and immunotherapy of STAD.
Authors
- Zhangming Chen
- Yang Huang (ORCID: https://orcid.org/0000-0002-6458-6069)
- Jianye Han
- Aman Xu (ORCID: https://orcid.org/0000-0001-5656-0646)
- Chen Chen (ORCID: https://orcid.org/0000-0001-7075-8501)
- Yue Qiu (ORCID: https://orcid.org/0000-0002-2474-8107)
- Yuanmin Xu
- Minzhi Sun
- Weiwei Yuan (ORCID: https://orcid.org/0009-0004-2686-6918)
Institutions
- Anhui Medical University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Aging
- Published
- 2024-08-23
- DOI
- https://doi.org/10.18632/aging.206079
- Citations
- 4
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Anhui Provincial Key Research and Development Plan